COMPLEGENT
Live / Registered — Registered (as of 25 Jul 2023)
What this means for you
Registered since 25 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97347406
- Registration number
- 7118859
- Mark type
- Stylized text
- Filed
- 05 Apr 2022
- Published for opposition
- 09 May 2023
- Registered
- 25 Jul 2023
- Attorney of record
- Kaushal Odedra
Goods and services
- Class 005 — Pharmaceuticals: Host cells for medical or clinical use; cells for medical use, namely, cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; cells for medical use, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; Pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors being pharmaceutical products for treatment of blood pressure, agents for the treatment of asthma, antitussives and expectorants, stomachics and digestives for pharmaceutical purposes, antacids; hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis; corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, Crohn's disease, and chronic active hepatitis; estrogen and progesterone preparations used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents; cataplasms for the treatment of bruises, lumbago and stiff shoulder; pharmaceutical preparations used to treat hair disorders; vitamin preparations; food enriching agents, namely, vitamin supplements, for treating vitamin deficiencies; anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa rolls and sticks for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs; germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and agricultural use; antiseptics, drugs for treating arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for pharmaceutical in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, drugs for treating Parkinson's disease; pharmaceuticals, namely, minor tranquilizers, and anti anxiety agents; pharmaceuticals, namely, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system; pharmaceuticals, namely, anti-bacterial preparations in the nature of antibacterial substances for medical purposes, monolithic preparations in the nature of substances for medical purposes, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations in the nature of radioactive substances, nutritive substances for microorganisms for medical purposes, pharmaceutical preparations for improving the metabolism and the peripheral circulation, blood plasma in the nature of plasma substitutes and extracorporeal circulation flow improvement preparations; diuretic and anti-hypertensive preparations; in vitro diagnostic reagents for medical use; in vitro extra corporeal diagnostic reagents for medical use; in vitro x-ray contrast agents for medical use; in vitro diagnostic media for medical use, and pharmaceutical preparations for the treatment of insomnia and other sleep related diseases
Owner
- Kyowa Kirin Co., Ltd., Tokyo, JP
- Kyowa Kirin Co., Ltd., Tokyo, JP
- Kyowa Kirin Co., Ltd., Tokyo, JP
Prosecution history
- 25 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 May 2023 — PUBLISHED FOR OPPOSITION
- 19 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Apr 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 31 Mar 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 25 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Feb 2023 — NON-FINAL ACTION E-MAILED
- 14 Feb 2023 — NON-FINAL ACTION WRITTEN
- 29 Dec 2022 — ASSIGNED TO EXAMINER